Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSIW) Interest & Investment Income (2022 - 2025)

Historic Interest & Investment Income for TriSalus Life Sciences (TLSIW) over the last 4 years, with Q3 2025 value amounting to $170000.0.

  • TriSalus Life Sciences' Interest & Investment Income rose 759.49% to $170000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $435000.0, marking a year-over-year decrease of 2639.59%. This contributed to the annual value of $404000.0 for FY2024, which is 626.45% down from last year.
  • Latest data reveals that TriSalus Life Sciences reported Interest & Investment Income of $170000.0 as of Q3 2025, which was up 759.49% from $134000.0 recorded in Q2 2025.
  • TriSalus Life Sciences' 5-year Interest & Investment Income high stood at $314714.0 for Q2 2022, and its period low was $35000.0 during Q1 2023.
  • Over the past 4 years, TriSalus Life Sciences' median Interest & Investment Income value was $97000.0 (recorded in 2024), while the average stood at $115927.6.
  • In the last 5 years, TriSalus Life Sciences' Interest & Investment Income plummeted by 8856.1% in 2023 and then surged by 16944.44% in 2024.
  • Over the past 4 years, TriSalus Life Sciences' Interest & Investment Income (Quarter) stood at $105000.0 in 2022, then surged by 132.38% to $244000.0 in 2023, then plummeted by 76.64% to $57000.0 in 2024, then surged by 198.25% to $170000.0 in 2025.
  • Its last three reported values are $170000.0 in Q3 2025, $134000.0 for Q2 2025, and $74000.0 during Q1 2025.